Figure 4.
Bioavailability of pegfilgrastim and Maxy‐G34. Curves are based on model simulations of the final pharmacokinetic model.
Bioavailability of pegfilgrastim and Maxy‐G34. Curves are based on model simulations of the final pharmacokinetic model.